Navigation Links
Rensselaer Polytechnic Institute wins $2.45 million grant to support stem cell research
Date:5/25/2010

Troy, N.Y. Rensselaer Polytechnic Institute and principal investigator Glenn Monastersky have been awarded a four-year $2.45 million grant from the New York Stem Cell Science Program (NYSTEM) of the Empire State Stem Cell Board.

Monastersky, director of operations at the Center for Biotechnology and Interdisciplinary Studies (CBIS), said the grant will be used to create an upstate center of excellence for basic stem cell research within the CBIS.

"The funds awarded today by New York state will be used to build out sophisticated laboratories with high-throughput culture and imaging equipment in the CBIS, dedicated to the very specialized needs of stem cell researchers," Monastersky said.

Rensselaer is already active in stem cell research. A number of Rensselaer faculty members, including NYSTEM-funded researchers Robert Linhardt and Deanna Thompson, maintain stem cell research programs within the CBIS. But Monastersky said the new grant will greatly enhance the program.

A key goal of the grant is to encourage upstate researchers to take advantage of the availability of the Rensselaer stem cell facility. Monastersky said that Rensselaer will be working with several key players in the field.

"The idea was to create an upstate center of excellence so we can maximize the research that's going on in New York state," Monastersky said. "These facilities and the associated scientific staff will enhance collaborations with several New York state partners, including the New York Neural Stem Cell Institute, Albany Medical College, and the Ordway Institute."

Scientific colleagues from the University at Albany-SUNY, the University of Rochester Medical School, Northeast Health System, and the Trudeau Institute also will participate in guiding the research efforts with Monastersky.

"Our goal is to become an important location for stem cell research in New York state," Monastersky said.

Stem cell therapies hold promise for treatments of human diseases and traumatic injuries because they can be grown into specialized cells like nerve, muscle, and bone, and could therefore be used to regenerate missing or damaged cells.

Rensselaer plans to work with existing stem cell lines, Monastersky said.

Monastersky said the focus of the research in the CBIS will be the basic science critical to development of stem-cell based therapies for human diseases and traumatic injuries. Growing the cells and controlling their "differentiation" guiding their development into the specialized cell types of the human body are key scientific challenges.

"All of these totipotent cells from the very early embryo are identical, and have the potential to develop into any of the mature cell types of the body," Monastersky said. "To use them, we need to know how to guide the development of cultured embryonic stem cells into these specialized cell types e.g., nerve, muscle, and bone cells."

Space within the existing collection of Research Cores in the CBIS will be created as a dedicated resource for stem cell research, for Rensselaer investigators, and for stem cell researchers from other institutions, particularly across New York state.

"We are excited that this funding will enhance our ongoing efforts to recruit world-class faculty for our faculty Constellation in Tissue Engineering and Regenerative Medicine, which is located in the CBIS," Monastersky said.


'/>"/>

Contact: Mary Martialay
martim12@rpi.edu
518-276-2146
Rensselaer Polytechnic Institute
Source:Eurekalert

Related biology news :

1. Deadly dose: Rensselaer heparin expert helps uncover source of lethal contamination
2. Trustee makes donation to start new solar energy research center at Rensselaer
3. Rensselaer receives more than $2 million from New York State to fund stem cell research
4. Rensselaer leads effort to replace 1 of the most widely used drugs in American hospitals
5. Rensselaer researchers to send bacteria into orbit aboard space shuttle Atlantis
6. Palm Beach County wants to establish a Max Planck Institute in Florida
7. Midlands Consortium delighted to be chosen to host £1 billion energy institute
8. $22 million gift from Alfred Taubman launches new biomedical research institute
9. 3 Columbia University Medical Center faculty elected to Institute of Medicine
10. Stowers Institutes Xie Lab demonstrates dual intrinsic and extrinsic control of stem cell aging
11. Weizmann Institute scientists discover: A risk distribution law for evolution
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/29/2016)... Nearly one billion matches per second with DERMALOG,s high-speed AFIS    ... ... DERMALOG is Germany's largest Multi-Biometric supplier: The ... Identification Systems) ... Germany's largest Multi-Biometric supplier: The company's Fingerprint Identification System is part of ...
(Date:11/22/2016)... According to the new market research report "Biometric ... Signature, Voice), Multi-Factor), Component (Hardware and Software), Function (Contact and Non-contact), Application, ... is expected to grow from USD 10.74 Billion in 2015 to reach ... and 2022. Continue Reading ... ...
(Date:11/19/2016)... , Nov. 18, 2016 Securus Technologies, ... solutions for public safety, investigation, corrections and monitoring, announced ... smaller competitor, ICSolutions, to have an independent technology judge ... the most modern high tech/sophisticated telephone calling platform, and ... customers that they do most of what we do ...
Breaking Biology News(10 mins):
(Date:12/2/2016)... , ... December 01, 2016 , ... ... long-term client Nanowear on their recent FDA Class II 510(k) clearance for their ... significant hurdle in commercializing remote cardiac monitoring devices that rely on cloth-based nanosensors. ...
(Date:12/2/2016)... a world leader in rapid infectious disease tests, introduced the Company,s newest product, the ... (Photo: http://photos.prnewswire.com/prnh/20161201/444905 ) Continue Reading ... ... , , bioLytical was invited by the ... INSTI HIV Self Test to 350 pharmacy representatives in Nairobi ...
(Date:11/30/2016)... Biotest Pharmaceuticals Corporation (BPC), a leading manufacturer ... addition of its newest plasma collection center located at ... The 15,200 square foot state-of-the-art facility officially opened its ... the total number of BPC,s plasma collection centers to ... Chief Executive Officer said "We are pleased to become ...
(Date:11/30/2016)... November 2016   Merck , ein ... Unterzeichnung einer Reihe von Vereinbarungen mit Evotec ... AG Screeningleistungen für Mercks Palette genetischer Reagenzien ... auf diese Bibliotheken in Kombination mit Evotecs ... Weg zur Ermittlung und Erforschung neuer Arzneimitteltargets.    ...
Breaking Biology Technology: